AI outperforms old tests for fatty liver diagnosis?
NCT ID NCT07305636
First seen Jan 04, 2026 · Last updated May 18, 2026 · Updated 24 times
Summary
This study tested whether artificial intelligence (AI) could more accurately diagnose liver scarring (fibrosis) in people with metabolic fatty liver disease (MAFLD). Researchers compared AI models using ultrasound and clinical data to standard non-invasive blood tests in 522 Egyptian adults. The goal is to improve early detection and reduce the need for invasive liver biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAFLD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Faculty of Medicine
Tanta, Egypt
Conditions
Explore the condition pages connected to this study.